224 related articles for article (PubMed ID: 1627142)
1. The N-terminal region of HIV-1 integrase is required for integration activity, but not for DNA-binding.
Schauer M; Billich A
Biochem Biophys Res Commun; 1992 Jun; 185(3):874-80. PubMed ID: 1627142
[TBL] [Abstract][Full Text] [Related]
2. Quantitative in vitro assay for human immunodeficiency virus deoxyribonucleic acid integration.
Carteau S; Mouscadet JF; Goulaouic H; Subra F; Auclair C
Arch Biochem Biophys; 1993 Feb; 300(2):756-60. PubMed ID: 8434953
[TBL] [Abstract][Full Text] [Related]
3. Substrate specificity of recombinant human immunodeficiency virus integrase protein.
LaFemina RL; Callahan PL; Cordingley MG
J Virol; 1991 Oct; 65(10):5624-30. PubMed ID: 1895409
[TBL] [Abstract][Full Text] [Related]
4. Characterization of the human spuma retrovirus integrase by site-directed mutagenesis, by complementation analysis, and by swapping the zinc finger domain of HIV-1.
Pahl A; Flügel RM
J Biol Chem; 1995 Feb; 270(7):2957-66. PubMed ID: 7852375
[TBL] [Abstract][Full Text] [Related]
5. The metal ion-induced cooperative binding of HIV-1 integrase to DNA exhibits a marked preference for Mn(II) rather than Mg(II).
Pemberton IK; Buckle M; Buc H
J Biol Chem; 1996 Jan; 271(3):1498-506. PubMed ID: 8576144
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of the integrase of human immunodeficiency virus (HIV) type 1 by anti-HIV plant proteins MAP30 and GAP31.
Lee-Huang S; Huang PL; Huang PL; Bourinbaiar AS; Chen HC; Kung HF
Proc Natl Acad Sci U S A; 1995 Sep; 92(19):8818-22. PubMed ID: 7568024
[TBL] [Abstract][Full Text] [Related]
7. Effect of topoisomerase inhibitors on the in vitro HIV DNA integration reaction.
Carteau S; Mouscadet JF; Goulaouic H; Subra F; Auclair C
Biochem Biophys Res Commun; 1993 May; 192(3):1409-14. PubMed ID: 8389550
[TBL] [Abstract][Full Text] [Related]
8. Characterization of human immunodeficiency virus type 1 integrase expressed in Escherichia coli and analysis of variants with amino-terminal mutations.
Vincent KA; Ellison V; Chow SA; Brown PO
J Virol; 1993 Jan; 67(1):425-37. PubMed ID: 8416376
[TBL] [Abstract][Full Text] [Related]
9. Genetic analysis of human immunodeficiency virus type 1 integrase and the U3 att site: unusual phenotype of mutants in the zinc finger-like domain.
Masuda T; Planelles V; Krogstad P; Chen IS
J Virol; 1995 Nov; 69(11):6687-96. PubMed ID: 7474078
[TBL] [Abstract][Full Text] [Related]
10. Mapping domains of retroviral integrase responsible for viral DNA specificity and target site selection by analysis of chimeras between human immunodeficiency virus type 1 and visna virus integrases.
Katzman M; Sudol M
J Virol; 1995 Sep; 69(9):5687-96. PubMed ID: 7637015
[TBL] [Abstract][Full Text] [Related]
11. Human immunodeficiency virus type 1 integrase stabilizes a linearized HIV-1 LTR plasmid in vivo.
Faust EA; Acel A; Udashkin B; Wainberg MA
Biochem Mol Biol Int; 1995 Jul; 36(4):745-58. PubMed ID: 8528137
[TBL] [Abstract][Full Text] [Related]
12. Sequences in the human immunodeficiency virus type 1 U3 region required for in vivo and in vitro integration.
Reicin AS; Kalpana G; Paik S; Marmon S; Goff S
J Virol; 1995 Sep; 69(9):5904-7. PubMed ID: 7637038
[TBL] [Abstract][Full Text] [Related]
13. Both substrate and target oligonucleotide sequences affect in vitro integration mediated by human immunodeficiency virus type 1 integrase protein produced in Saccharomyces cerevisiae.
Leavitt AD; Rose RB; Varmus HE
J Virol; 1992 Apr; 66(4):2359-68. PubMed ID: 1548767
[TBL] [Abstract][Full Text] [Related]
14. Directed integration of viral DNA mediated by fusion proteins consisting of human immunodeficiency virus type 1 integrase and Escherichia coli LexA protein.
Goulaouic H; Chow SA
J Virol; 1996 Jan; 70(1):37-46. PubMed ID: 8523550
[TBL] [Abstract][Full Text] [Related]
15. Juxtaposition of two viral DNA ends in a bimolecular disintegration reaction mediated by multimers of human immunodeficiency virus type 1 or murine leukemia virus integrase.
Chow SA; Brown PO
J Virol; 1994 Dec; 68(12):7869-78. PubMed ID: 7966577
[TBL] [Abstract][Full Text] [Related]
16. Isolation of high-affinity RNA ligands to HIV-1 integrase from a random pool.
Allen P; Worland S; Gold L
Virology; 1995 Jun; 209(2):327-36. PubMed ID: 7778267
[TBL] [Abstract][Full Text] [Related]
17. Viral long terminal repeat substrate binding characteristics of the human immunodeficiency virus type 1 integrase.
Hazuda DJ; Wolfe AL; Hastings JC; Robbins HL; Graham PL; LaFemina RL; Emini EA
J Biol Chem; 1994 Feb; 269(6):3999-4004. PubMed ID: 8307956
[TBL] [Abstract][Full Text] [Related]
18. Rous sarcoma virus integrase protein: mapping functions for catalysis and substrate binding.
Bushman FD; Wang B
J Virol; 1994 Apr; 68(4):2215-23. PubMed ID: 8139006
[TBL] [Abstract][Full Text] [Related]
19. Activities and substrate specificity of the evolutionarily conserved central domain of retroviral integrase.
Kulkosky J; Katz RA; Merkel G; Skalka AM
Virology; 1995 Jan; 206(1):448-56. PubMed ID: 7831800
[TBL] [Abstract][Full Text] [Related]
20. Inhibitory effect of the polyanionic drug suramin on the in vitro HIV DNA integration reaction.
Carteau S; Mouscadet JF; Goulaouic H; Subra F; Auclair C
Arch Biochem Biophys; 1993 Sep; 305(2):606-10. PubMed ID: 8373200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
